The traditional process of melanoma care delivery can differ substantially among providers regarding screening laboratories, staging work-ups, surgical margins, and outpatient versus inpatient surgical management.
It has been suggested that multidisciplinary care may provide a more cost-effective management approach.
We sought to evaluate whether coordinated multidisciplinary melanoma care that follows evidence-based, consensus-approved clinical practice guidelines at a large academic medical center can provide a more efficient alternative to traditional community-based strategies with clinical outcomes that are at least equivalent.
The University of Michigan Multidisciplinary Melanoma Clinic (MDMC) possesses a database of demographic, clinical, and treatment information for all patients seen since its inception.
A consecutive sample of 104 patients with local disease who were treated in the Michigan community were compared with 104 blindly selected subjects treated at the MDMC during an identical time period, matched for Breslow depth and melanoma body site.
Patients treated in the MDMC would save a third party payer roughly $1600 per patient when compared with a similar group treated in the Michigan community.
Surgical morbidity, length of hospitalization, and long-term survival of MDMC patients were similar to those reported in the literature. (...)
Mots-clés Pascal : Mélanome malin, Codage, Classification, Stade clinique, Traitement, Analyse coût, Economie santé, Etats Unis, Amérique du Nord, Amérique, Homme, Tumeur maligne, Peau pathologie
Mots-clés Pascal anglais : Malignant melanoma, Coding, Classification, Clinical stage, Treatment, Cost analysis, Health economy, United States, North America, America, Human, Malignant tumor, Skin disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0280982
Code Inist : 002B08A. Création : 27/11/1998.